A Clinical Trial of P134 Cells in Recurrent Glioblastoma

计划入组 26 人 · 首次发布于 2026 年 1 月 6 日

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

计划入组 35 人 · 首次发布于 2025 年 3 月 21 日

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

计划入组 36 人 · 首次发布于 2022 年 3 月 17 日

Ginkgolides Injection

Shenqifuzheng injection

XingNaoJing Injection

SAVIOR LIFETEC CORPORATION TAINAN BRANCH INJECTION PLANT

Taiwan

Gamida Cell

Israel

GAMIDA CELL INC.

United States

Porton Advanced Accelerates Development of Innovative Cell Therapies for Solid Tumors with Key Partnerships

Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results

FDA Approves Larger Vial Size of Nelarabine Injection for T-Cell Leukemia and Lymphoma Treatment